Search research articles
Contact Us
Filters
Showing results (531-540 of 933) with videos related to
Page
of 94
Sort By:
Onkologie
|
July 8, 2011
Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients
Matthias W Beckmann, Cosima Brucker, Volker Hanf, et al.
Cell Death & Disease
|
February 26, 2020
EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells
Pablo Lindner, Sushmita Paul, Markus Eckstein, et al.
Genes
|
July 2, 2021
Molecular Characterization of Muellerian Tumors of the Urinary Tract
Nadina Ortiz-Brüchle, Sophie Wucherpfennig, Michael Rose, et al.
Cancers
|
January 11, 2022
Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
Barbara Schuster, Markus Hecht, Manfred Schmidt, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
October 25, 2021
Mucosal Mast Cell Distribution in the Gastrointestinal Tract of Children: A Preliminary Study for Establishing Reference Values
Christoph Ehrsam, Tobias Rechenauer, Ida Allabauer, et al.
Molecular Oncology
|
May 10, 2019
Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma
Ana Carolina Monteiro, Julienne K Muenzner, Fernando Andrade, et al.
The American Journal of Pathology
|
March 17, 2009
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis
Thomas Amann, Ulrike Maegdefrau, Arndt Hartmann, et al.
Annals of Surgery
|
April 16, 2011
Hepatocyte nuclear factor (HNF) 4α expression distinguishes ampullary cancer subtypes and prognosis after resection
Florian Ehehalt, Petra Rümmele, Stephan Kersting, et al.
Scientific Reports
|
November 3, 2020
Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior
Adrian Georg Simon, Yuri Tolkach, Laura Kristin Esser, et al.
Urologic Oncology
|
July 31, 2021
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer
Danijel Sikic, Markus Eckstein, Veronika Weyerer, et al.
Page
of 94
Search research articles
Search
Showing results (531-540 of 933) with videos related to
Sort By:
Page
of 94
Onkologie
|
July 8, 2011
Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients
Matthias W Beckmann, Cosima Brucker, Volker Hanf, et al.
Cell Death & Disease
|
February 26, 2020
EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells
Pablo Lindner, Sushmita Paul, Markus Eckstein, et al.
Genes
|
July 2, 2021
Molecular Characterization of Muellerian Tumors of the Urinary Tract
Nadina Ortiz-Brüchle, Sophie Wucherpfennig, Michael Rose, et al.
Cancers
|
January 11, 2022
Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
Barbara Schuster, Markus Hecht, Manfred Schmidt, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
October 25, 2021
Mucosal Mast Cell Distribution in the Gastrointestinal Tract of Children: A Preliminary Study for Establishing Reference Values
Christoph Ehrsam, Tobias Rechenauer, Ida Allabauer, et al.
Molecular Oncology
|
May 10, 2019
Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma
Ana Carolina Monteiro, Julienne K Muenzner, Fernando Andrade, et al.
The American Journal of Pathology
|
March 17, 2009
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis
Thomas Amann, Ulrike Maegdefrau, Arndt Hartmann, et al.
Annals of Surgery
|
April 16, 2011
Hepatocyte nuclear factor (HNF) 4α expression distinguishes ampullary cancer subtypes and prognosis after resection
Florian Ehehalt, Petra Rümmele, Stephan Kersting, et al.
Scientific Reports
|
November 3, 2020
Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior
Adrian Georg Simon, Yuri Tolkach, Laura Kristin Esser, et al.
Urologic Oncology
|
July 31, 2021
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer
Danijel Sikic, Markus Eckstein, Veronika Weyerer, et al.
Page
of 94